L&K Biomed Ltd. (KOSDAQ:156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,800.00
+160.00 (2.84%)
Last updated: Jun 25, 2025

L&K Biomed Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
35,85936,09229,90519,76715,37319,356
Upgrade
Other Revenue
-0--0-0-0-
Upgrade
35,85936,09229,90519,76715,37319,356
Upgrade
Revenue Growth (YoY)
14.58%20.69%51.28%28.59%-20.58%-27.16%
Upgrade
Cost of Revenue
6,3785,9504,2274,9758,0195,899
Upgrade
Gross Profit
29,48130,14225,67814,7927,35413,457
Upgrade
Selling, General & Admin
23,42822,20120,96724,26119,64713,696
Upgrade
Research & Development
2,2662,0531,3291,3691,358977.97
Upgrade
Operating Expenses
28,20227,06423,64427,53022,63417,315
Upgrade
Operating Income
1,2793,0782,034-12,738-15,280-3,859
Upgrade
Interest Expense
-3,149-2,681-2,002-2,206-1,380-1,145
Upgrade
Interest & Investment Income
670.98589.61384.99219.84107.61127.55
Upgrade
Earnings From Equity Investments
-300-300-1,172-1,199-556.16-420.88
Upgrade
Currency Exchange Gain (Loss)
5,9987,560740.731,9612,301-1,707
Upgrade
Other Non Operating Income (Expenses)
1,5171,621-330.56-2,0274,630639.47
Upgrade
EBT Excluding Unusual Items
6,0169,866-343.96-15,989-10,178-6,365
Upgrade
Gain (Loss) on Sale of Investments
75.1475.1449.41-1,684-
Upgrade
Gain (Loss) on Sale of Assets
363.89254.516.24-65.73220.44-519.34
Upgrade
Asset Writedown
---16.8-243.71-623.87-2,355
Upgrade
Other Unusual Items
-237.36-380.94-6,173---
Upgrade
Pretax Income
6,2189,815-6,468-16,299-8,897-9,239
Upgrade
Income Tax Expense
-411.98663.59-1,229-65.764,7491,433
Upgrade
Earnings From Continuing Operations
6,6309,151-5,239-16,233-13,646-10,672
Upgrade
Minority Interest in Earnings
-1,052591.773,3722,6083,978-43.26
Upgrade
Net Income
5,5789,743-1,867-13,625-9,669-10,715
Upgrade
Net Income to Common
5,5789,743-1,867-13,625-9,669-10,715
Upgrade
Shares Outstanding (Basic)
202016131312
Upgrade
Shares Outstanding (Diluted)
222216131312
Upgrade
Shares Change (YoY)
21.17%32.67%21.04%0.07%12.57%14.15%
Upgrade
EPS (Basic)
279.78488.71-115.17-1017.14-722.29-901.11
Upgrade
EPS (Diluted)
254.52448.22-115.17-1017.14-722.29-901.11
Upgrade
Free Cash Flow
-8,072-8,015-3,417-6,684-10,501-2,721
Upgrade
Free Cash Flow Per Share
-375.24-372.60-210.77-498.99-784.49-228.82
Upgrade
Gross Margin
82.21%83.52%85.87%74.83%47.84%69.52%
Upgrade
Operating Margin
3.57%8.53%6.80%-64.44%-99.40%-19.94%
Upgrade
Profit Margin
15.55%27.00%-6.24%-68.93%-62.90%-55.36%
Upgrade
Free Cash Flow Margin
-22.51%-22.21%-11.43%-33.81%-68.31%-14.06%
Upgrade
EBITDA
3,8995,6504,347-10,436-13,555-770.01
Upgrade
EBITDA Margin
10.87%15.65%14.54%-52.80%-88.18%-3.98%
Upgrade
D&A For EBITDA
2,6202,5722,3132,3021,7253,089
Upgrade
EBIT
1,2793,0782,034-12,738-15,280-3,859
Upgrade
EBIT Margin
3.57%8.53%6.80%-64.44%-99.40%-19.94%
Upgrade
Effective Tax Rate
-6.76%----
Upgrade
Advertising Expenses
-227.72130.35176.7178.0768.79
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.